Conduction Abnormalities After Transcatheter Aortic Valve Replacement
Transcatheter aortic valve replacement (TAVR) has been established as a therapeutic option for patients with severe symptomatic aortic stenosis who are of intermediate or higher surgical risk. Several periprocedural complications are reduced with newer transcatheter heart valve generations; however,...
Guardado en:
Autores principales: | Somsupha Kanjanauthai, Kabir Bhasin, Luigi Pirelli, Chad A Kliger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c4ad00e2062e4bf6ab807ce220bfecaa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Shockwave and Non-transfemoral Transcatheter Aortic Valve Replacement
por: Eden C Payabyab, et al.
Publicado: (2021) -
Evaluation and Management of Heart Block After Transcatheter Aortic Valve Replacement
por: Anthony J Mazzella, et al.
Publicado: (2021) -
Intraventricular Conduction Disturbances After Transcatheter Aortic Valve Implantation
por: Shu-I Lin, et al.
Publicado: (2020) -
Antithrombotic Therapy After Transcatheter Aortic Valve Implantation
por: Leslie Marisol Lugo, et al.
Publicado: (2020) -
Transcatheter aortic valve replacement using the iSleeve expandable sheath in small femoral arteries
por: Rickard Linder, et al.
Publicado: (2021)